108 related articles for article (PubMed ID: 386322)
1. The correlation of kidney transplant survival with lymphocyte mediated cytotoxicity on B cell targets.
Nathan P; Plessinger RT; First MR
Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():62-7. PubMed ID: 386322
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometry crossmatching and primary cadaver kidney graft outcome: relevance of T and B cell targets, historic sera and autologous controls.
LeFor WM; Ackermann JR; Alveranga DY; Bowers VD; Heinrichs DF; Kahana L; Shires DL; Weinstein SS; Wright CE
Clin Transplant; 1996 Dec; 10(6 Pt 2):601-6. PubMed ID: 8996750
[TBL] [Abstract][Full Text] [Related]
3. Renal allograft survival in patients with positive donor-specific B lymphocyte crossmatches.
Noreen HJ; van der Hagen E; Bach FH; Fryd D; Ascher N; Simmons RL; Najarian JS
Transplant Proc; 1987 Feb; 19(1 Pt 1):780-1. PubMed ID: 3274873
[No Abstract] [Full Text] [Related]
4. Flow cytometry crossmatch before kidney transplantation in contemporary practice: target cell utilization, results patterns, and associated long-term graft survival.
Lentine KL; Graff RJ; Xiao H; Modanlou KA; Salvalaggio PR; Brennan DC; Pinsky BW; Burroughs TE; Schnitzler MA
Clin Transpl; 2008; ():253-66. PubMed ID: 19708460
[TBL] [Abstract][Full Text] [Related]
5. Detection of antidonor antibody: advantages of fibroblast target cells.
Halloran PF; Aprile M; Haddad G; Robinette M
Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():49-55. PubMed ID: 386320
[TBL] [Abstract][Full Text] [Related]
6. T and B cell patterns in irreversibly rejected human renal allografts. Correlation of morphology with surface markers and cytotoxic capacity of the isolated lymphoid infiltrates.
Busch GJ; Schamberg JF; Moretz RC; Strom TB; Tilney NL; Carpenter CB
Lab Invest; 1976 Sep; 35(3):272-80. PubMed ID: 785094
[TBL] [Abstract][Full Text] [Related]
7. Adverse presensitization to renal transplants. Detection by utilization of a D locus antigen-defined lymphoblastoid cell panel as targets in antibody-dependent cell-mediated cytotoxicity assays.
Suthanthiran M; Fotino M; Cheigh JS; Rubin AL; Novogrodsky A; Stenzel KH
Transplantation; 1979 May; 27(5):333-7. PubMed ID: 373190
[TBL] [Abstract][Full Text] [Related]
8. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
[TBL] [Abstract][Full Text] [Related]
9. Analysis of positive kidney, heart, and liver transplant crossmatches reported to the Collaborative Transplant Study.
Opelz G; Döhler B; Süsal C
Hum Immunol; 2009 Aug; 70(8):627-30. PubMed ID: 19375469
[TBL] [Abstract][Full Text] [Related]
10. The effector cells in human peripheral blood mediating mitogen-induced cellular cytotoxicity and antibody-dependent cellular cytotoxicity.
Nelson DL; Bundy BM; Pitchon HE; Blaese RM; Strober W
J Immunol; 1976 Nov; 117(5 Pt 1):1472-81. PubMed ID: 1087314
[TBL] [Abstract][Full Text] [Related]
11. High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function.
Nickel P; Bold G; Presber F; Biti D; Babel N; Kreutzer S; Pratschke J; Schönemann C; Kern F; Volk HD; Reinke P
Transpl Immunol; 2009 Mar; 20(4):238-42. PubMed ID: 19032982
[TBL] [Abstract][Full Text] [Related]
12. Donor-specific cell-mediated cytotoxicity in renal allograft recipients.
Dickmeiss E
Acta Pathol Microbiol Scand C; 1979 Dec; 87(6):371-76. PubMed ID: 397716
[TBL] [Abstract][Full Text] [Related]
13. Renal graft survival is not influenced by a positive flow B-cell crossmatch.
Bryan CF; Wakefield M; Reese JC; Shield CF; Warady BA; Winklhofer FT; Murillo D
Clin Transplant; 2007; 21(1):72-9. PubMed ID: 17302594
[TBL] [Abstract][Full Text] [Related]
14. A micromethod for prospectively testing lymphocyte-mediated cytotoxicity (LMC) using fresh or frozen cells labelled with a fluorescent dye.
Nathan P; Plessinger RT
Tissue Antigens; 1979 Sep; 14(3):205-12. PubMed ID: 160631
[TBL] [Abstract][Full Text] [Related]
15. Effects of histocompatibility testing versus immunoreactive predisposition on kidney transplant survival.
Kyriakides GK; Severyn W; Fuller L; Esquenazi V; Flaa C; Olson L; Miller J
Surgery; 1982 Aug; 92(2):354-61. PubMed ID: 6213054
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxic antibodies to B lymphocytes in kidney transplant patients.
Luciani G; Castagneto M; Monari C; Renna E
Transplant Proc; 1979 Jun; 11(2):1265-6. PubMed ID: 382503
[No Abstract] [Full Text] [Related]
17. Anti-donor immune responses in prediction of transplant rejection.
Stiller CR; StC Sinclair NR; Abrahams S; McGirr D; Singh H; Howson WT; Ulan RA
N Engl J Med; 1976 Apr; 294(18):978-82. PubMed ID: 130555
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of B and T cell antibodies in kidney transplantation.
Lenhard V; Rettwitz W; Dreikorn K; Röhl L
Proc Eur Dial Transplant Assoc; 1980; 17():478-82. PubMed ID: 7017693
[TBL] [Abstract][Full Text] [Related]
19. Immunologic monitoring of the renal transplant recipient.
Suthanthiran M; Garovoy MR
Urol Clin North Am; 1983 May; 10(2):315-25. PubMed ID: 6222530
[No Abstract] [Full Text] [Related]
20. HLA-D antigen disparity and HLA-DRw antibodies in intrafamilial renal allograft survival.
Cochrum K; Hanes D; Van Speybroeck J; Perkins H; Ferrone S; Indeveri F; Amend W; Vincenti F; Feduska N; Salvatierra O
Transplant Proc; 1979 Mar; 11(1):404-10. PubMed ID: 156426
[No Abstract] [Full Text] [Related]
[Next] [New Search]
